Review



cd8 cy chrome  (Bio-Rad)


Bioz Verified Symbol Bio-Rad is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    Bio-Rad cd8 cy chrome
    Cd8 Cy Chrome, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 110 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd8 cy chrome/product/Bio-Rad
    Average 94 stars, based on 110 article reviews
    cd8 cy chrome - by Bioz Stars, 2026-03
    94/100 stars

    Images



    Similar Products

    cy chrome anti cd8  (R&D Systems)
    95
    R&D Systems cy chrome anti cd8
    Cy Chrome Anti Cd8, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cy chrome anti cd8/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    cy chrome anti cd8 - by Bioz Stars, 2026-03
    95/100 stars
    		  Buy from Supplier
    anti-human cd8 conjugated cy-chrome  (Becton Dickinson)
    90
    Becton Dickinson anti-human cd8 conjugated cy-chrome
    Anti Human Cd8 Conjugated Cy Chrome, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-human cd8 conjugated cy-chrome/product/Becton Dickinson
    Average 90 stars, based on 1 article reviews
    anti-human cd8 conjugated cy-chrome - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    cy-chrome-conjugated mabs against cd8 (53-6.7)  (Becton Dickinson)
    90
    Becton Dickinson cy-chrome-conjugated mabs against cd8 (53-6.7)
    (A) Flow cytometry analysis of tumor infiltrating lymphocytes and tumor draining lymph node cells. Tumor bearing mice were treated with each Ab on day 9 and 12. Tumors and lymph nodes were harvested on day 13. The figure on each plot shows the percentage of <t>CD3+CD4+</t> T cells or <t>CD3+CD8+</t> T cells. (B and C) Immunofluorescence staining of <t>CD3</t> and CD8 in MC38 tumor (B) or B16-F10 tumor (C) (scale bar = 100 μm). Tumor bearing mice were treated with each Ab on day 9 and 12. Tumors were harvested on day 13. Number of cells were manually counted in randomly selected 5 fields per tumor section (MC38; n = 4 per group, B16-F10; n = 5 per group). Data are shown as mean ± SE. Statistical significance between groups was determined by Student’s t test.
    Cy Chrome Conjugated Mabs Against Cd8 (53 6.7), supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cy-chrome-conjugated mabs against cd8 (53-6.7)/product/Becton Dickinson
    Average 90 stars, based on 1 article reviews
    cy-chrome-conjugated mabs against cd8 (53-6.7) - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    cy-chrome-conjugated anti-cd8  (Becton Dickinson)
    90
    Becton Dickinson cy-chrome-conjugated anti-cd8
    (A) Flow cytometry analysis of tumor infiltrating lymphocytes and tumor draining lymph node cells. Tumor bearing mice were treated with each Ab on day 9 and 12. Tumors and lymph nodes were harvested on day 13. The figure on each plot shows the percentage of <t>CD3+CD4+</t> T cells or <t>CD3+CD8+</t> T cells. (B and C) Immunofluorescence staining of <t>CD3</t> and CD8 in MC38 tumor (B) or B16-F10 tumor (C) (scale bar = 100 μm). Tumor bearing mice were treated with each Ab on day 9 and 12. Tumors were harvested on day 13. Number of cells were manually counted in randomly selected 5 fields per tumor section (MC38; n = 4 per group, B16-F10; n = 5 per group). Data are shown as mean ± SE. Statistical significance between groups was determined by Student’s t test.
    Cy Chrome Conjugated Anti Cd8, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cy-chrome-conjugated anti-cd8/product/Becton Dickinson
    Average 90 stars, based on 1 article reviews
    cy-chrome-conjugated anti-cd8 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    cy-chrome conjugated anti-cd8  (Becton Dickinson)
    90
    Becton Dickinson cy-chrome conjugated anti-cd8
    (A) Flow cytometry analysis of tumor infiltrating lymphocytes and tumor draining lymph node cells. Tumor bearing mice were treated with each Ab on day 9 and 12. Tumors and lymph nodes were harvested on day 13. The figure on each plot shows the percentage of <t>CD3+CD4+</t> T cells or <t>CD3+CD8+</t> T cells. (B and C) Immunofluorescence staining of <t>CD3</t> and CD8 in MC38 tumor (B) or B16-F10 tumor (C) (scale bar = 100 μm). Tumor bearing mice were treated with each Ab on day 9 and 12. Tumors were harvested on day 13. Number of cells were manually counted in randomly selected 5 fields per tumor section (MC38; n = 4 per group, B16-F10; n = 5 per group). Data are shown as mean ± SE. Statistical significance between groups was determined by Student’s t test.
    Cy Chrome Conjugated Anti Cd8, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cy-chrome conjugated anti-cd8/product/Becton Dickinson
    Average 90 stars, based on 1 article reviews
    cy-chrome conjugated anti-cd8 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    cy-chrome-conjugated cd8 mab  (Becton Dickinson)
    90
    Becton Dickinson cy-chrome-conjugated cd8 mab
    (A) Flow cytometry analysis of tumor infiltrating lymphocytes and tumor draining lymph node cells. Tumor bearing mice were treated with each Ab on day 9 and 12. Tumors and lymph nodes were harvested on day 13. The figure on each plot shows the percentage of <t>CD3+CD4+</t> T cells or <t>CD3+CD8+</t> T cells. (B and C) Immunofluorescence staining of <t>CD3</t> and CD8 in MC38 tumor (B) or B16-F10 tumor (C) (scale bar = 100 μm). Tumor bearing mice were treated with each Ab on day 9 and 12. Tumors were harvested on day 13. Number of cells were manually counted in randomly selected 5 fields per tumor section (MC38; n = 4 per group, B16-F10; n = 5 per group). Data are shown as mean ± SE. Statistical significance between groups was determined by Student’s t test.
    Cy Chrome Conjugated Cd8 Mab, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cy-chrome-conjugated cd8 mab/product/Becton Dickinson
    Average 90 stars, based on 1 article reviews
    cy-chrome-conjugated cd8 mab - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    cy-chrome-conjugated cd8  (Becton Dickinson)
    90
    Becton Dickinson cy-chrome-conjugated cd8
    (A) Flow cytometry analysis of tumor infiltrating lymphocytes and tumor draining lymph node cells. Tumor bearing mice were treated with each Ab on day 9 and 12. Tumors and lymph nodes were harvested on day 13. The figure on each plot shows the percentage of <t>CD3+CD4+</t> T cells or <t>CD3+CD8+</t> T cells. (B and C) Immunofluorescence staining of <t>CD3</t> and CD8 in MC38 tumor (B) or B16-F10 tumor (C) (scale bar = 100 μm). Tumor bearing mice were treated with each Ab on day 9 and 12. Tumors were harvested on day 13. Number of cells were manually counted in randomly selected 5 fields per tumor section (MC38; n = 4 per group, B16-F10; n = 5 per group). Data are shown as mean ± SE. Statistical significance between groups was determined by Student’s t test.
    Cy Chrome Conjugated Cd8, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cy-chrome-conjugated cd8/product/Becton Dickinson
    Average 90 stars, based on 1 article reviews
    cy-chrome-conjugated cd8 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    cy-chrome-labeled rat anti-mouse cd8  (Thermo Fisher)
    90
    Thermo Fisher cy-chrome-labeled rat anti-mouse cd8
    (A) Flow cytometry analysis of tumor infiltrating lymphocytes and tumor draining lymph node cells. Tumor bearing mice were treated with each Ab on day 9 and 12. Tumors and lymph nodes were harvested on day 13. The figure on each plot shows the percentage of <t>CD3+CD4+</t> T cells or <t>CD3+CD8+</t> T cells. (B and C) Immunofluorescence staining of <t>CD3</t> and CD8 in MC38 tumor (B) or B16-F10 tumor (C) (scale bar = 100 μm). Tumor bearing mice were treated with each Ab on day 9 and 12. Tumors were harvested on day 13. Number of cells were manually counted in randomly selected 5 fields per tumor section (MC38; n = 4 per group, B16-F10; n = 5 per group). Data are shown as mean ± SE. Statistical significance between groups was determined by Student’s t test.
    Cy Chrome Labeled Rat Anti Mouse Cd8, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cy-chrome-labeled rat anti-mouse cd8/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    cy-chrome-labeled rat anti-mouse cd8 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    cd8 cy chrome  (Bio-Rad)
    94
    Bio-Rad cd8 cy chrome
    (A) Flow cytometry analysis of tumor infiltrating lymphocytes and tumor draining lymph node cells. Tumor bearing mice were treated with each Ab on day 9 and 12. Tumors and lymph nodes were harvested on day 13. The figure on each plot shows the percentage of <t>CD3+CD4+</t> T cells or <t>CD3+CD8+</t> T cells. (B and C) Immunofluorescence staining of <t>CD3</t> and CD8 in MC38 tumor (B) or B16-F10 tumor (C) (scale bar = 100 μm). Tumor bearing mice were treated with each Ab on day 9 and 12. Tumors were harvested on day 13. Number of cells were manually counted in randomly selected 5 fields per tumor section (MC38; n = 4 per group, B16-F10; n = 5 per group). Data are shown as mean ± SE. Statistical significance between groups was determined by Student’s t test.
    Cd8 Cy Chrome, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd8 cy chrome/product/Bio-Rad
    Average 94 stars, based on 1 article reviews
    cd8 cy chrome - by Bioz Stars, 2026-03
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    (A) Flow cytometry analysis of tumor infiltrating lymphocytes and tumor draining lymph node cells. Tumor bearing mice were treated with each Ab on day 9 and 12. Tumors and lymph nodes were harvested on day 13. The figure on each plot shows the percentage of CD3+CD4+ T cells or CD3+CD8+ T cells. (B and C) Immunofluorescence staining of CD3 and CD8 in MC38 tumor (B) or B16-F10 tumor (C) (scale bar = 100 μm). Tumor bearing mice were treated with each Ab on day 9 and 12. Tumors were harvested on day 13. Number of cells were manually counted in randomly selected 5 fields per tumor section (MC38; n = 4 per group, B16-F10; n = 5 per group). Data are shown as mean ± SE. Statistical significance between groups was determined by Student’s t test.

    Journal: Cancer research

    Article Title: Multimodal molecular imaging detects early responses to immune checkpoint blockade

    doi: 10.1158/0008-5472.CAN-20-3182

    Figure Lengend Snippet: (A) Flow cytometry analysis of tumor infiltrating lymphocytes and tumor draining lymph node cells. Tumor bearing mice were treated with each Ab on day 9 and 12. Tumors and lymph nodes were harvested on day 13. The figure on each plot shows the percentage of CD3+CD4+ T cells or CD3+CD8+ T cells. (B and C) Immunofluorescence staining of CD3 and CD8 in MC38 tumor (B) or B16-F10 tumor (C) (scale bar = 100 μm). Tumor bearing mice were treated with each Ab on day 9 and 12. Tumors were harvested on day 13. Number of cells were manually counted in randomly selected 5 fields per tumor section (MC38; n = 4 per group, B16-F10; n = 5 per group). Data are shown as mean ± SE. Statistical significance between groups was determined by Student’s t test.

    Article Snippet: To analyze tumor infiltrating lymphocytes, single-cell suspensions were prepared from solid tumors by digestion with a mixture of 0.1 % collagenase, 0.01 % DNase, and 2.5 U/ml hyaluronidase for 3 h at 37 deg C. FITC-conjugated mAbs against CD4 (RM4-5); PE-conjugated mAbs against CD3; Cy-chrome-conjugated mAbs against CD8 (53-6.7) were purchased from BD Biosciences.

    Techniques: Flow Cytometry, Immunofluorescence, Staining